Whitehawk Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
516
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
WHWK
Whitehawk Therapeutics, Inc. is a preclinical-stage oncology company focused on developing advanced antibody-drug conjugate (ADC) therapies. The company applies next-wave platform technologies to established tumor biology to create treatments for difficult-to-treat cancers. Its portfolio features three ADC assets, which are engineered to overcome the limitations of first-generation predecessors through improved tumor targeting and clinical strategies. These assets are in-licensed from WuXi Biologics under an exclusive agreement for global development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 | 2026-05-29 | English | |
| 8-K | 2026-05-21 | English | |
| 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-13 | English | |
| 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-07 | English | |
| 3 Filing | 2025-12-02 | English | |
| 4 Filing | 2025-12-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 47894348 | S-3 | 2026-05-29 | English | ||
| 46754058 | 8-K | 2026-05-21 | English | ||
| 45579684 | 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-13 | English | ||
| 42980779 | 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-07 | English | ||
|
2025
11 filings
| |||||
| 29677370 | 3 Filing | 2025-12-02 | English | ||
| 29675686 | 4 Filing | 2025-12-02 | English | ||
| 29677454 | 10-Q Filing | 2025-11-06 | English | ||
| 29675803 | 8-K Filing | 2025-11-06 | English | ||
| 29677316 | SCHEDULE 13G Filing | 2025-08-25 | English | ||
| 29677462 | 10-Q Filing | 2025-08-07 | English | ||
| 29677395 | 8-K Filing | 2025-08-07 | English | ||
| 29675718 | 4 Filing | 2025-06-17 | English | ||
| 29675501 | 4 Filing | 2025-06-17 | English | ||
| 29677439 | 4 Filing | 2025-06-16 | English | ||
| 29677425 | 4 Filing | 2025-06-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Nautilus Biotechnology, Inc.
Develops a proteome analysis platform to quantify proteins …
|
NAUT | US | Professional, scientific and te… |
|
NeoImmuneTech, Inc.
A clinical-stage biopharma developing T cell-focused immuno…
|
950220 | US | Professional, scientific and te… |
|
Neovacs
Biotech firm developing immunotherapies and investing in Bi…
|
ALNEV | FR | Professional, scientific and te… |
|
NervGen Pharma Corp.
Clinical-stage biotech developing treatments to promote ner…
|
NGEN | CA | Professional, scientific and te… |
|
NEUREN PHARMACEUTICALS LIMITED
Develops innovative therapies for rare neurodevelopmental d…
|
NEU | NZ | Professional, scientific and te… |
|
NEURIZON THERAPEUTICS LIMITED
Clinical-stage developer of mTOR modulators for ALS and neu…
|
NUZ | AU | Professional, scientific and te… |
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Develops peptide-based therapeutics for neurodegenerative a…
|
NSB | AU | Professional, scientific and te… |
|
NEUROTECH INTERNATIONAL LIMITED
Clinical-stage biopharmaceutical company developing pediatr…
|
NTI | AU | Professional, scientific and te… |
|
NewAmsterdam Pharma Co N.V.
A clinical-stage biopharma developing therapies for metabol…
|
NAMS | NL | Professional, scientific and te… |
|
NEXALIS THERAPEUTICS LTD
Develops small molecule therapies for chronic inflammatory …
|
NX1 | AU | Professional, scientific and te… |
Whitehawk Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34276/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34276 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34276 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34276 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34276}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Whitehawk Therapeutics, Inc. (id: 34276)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.